Evidence shows that neuropeptide Y (NPY) neurons are involved in mediating the anorexigenic action of leptin via neuronal circuits in the hypothalamus. However, studies have produced limited data on the cellular processes involved and whether hypothalamic NPY neurons are susceptible to cellular leptin resistance. To investigate the direct regulation of NPY secretion by leptin, we used novel NPY-synthesizing, immortalized mHypoA-NPY/green fluorescent protein and mHypoA-59 hypothalamic cell lines derived from adult hypothalamic primary cultures. We report that leptin treatment significantly suppressed NPY secretion in the cells by approximately 20%. We found a decrease in c-fos expression upon leptin exposure, indicating deactivation or hyperpolarization of the neurons. Protein analysis indicated that leptin inhibits AMP-activated protein kinase (AMPK) activity and activates acetyl-coenzyme A carboxylase in NPY neurons, supporting the hypothesis of an AMPK-dependent mechanism. Inhibiting both AMPK with Compound C or phosphatidylinositol 3 kinase (PI3K) with 2-(4-morpholinyl)-8-phenyl-1(4H)-1-benzopyran-4-one hydrochloride prevented the leptin-mediated decrease in NPY secretion, indicating both AMPK-and PI3K-mediated mechanisms. Further, NPY secretion was stimulated by 30% by the AMPK activator, aminoimidazole carboxamide ribonucleotide. Importantly, prolonged leptin exposure in the mHypoA-NPY/ green fluorescent protein cells prevented leptin-induced changes in AMPK phosphorylation and suppression of NPY secretion, indicating that NPY neurons are susceptible to leptin resistance. Our studies indicate that AMPK and PI3K pathways are involved in leptin action in NPY neurons and that leptin resistance blocks the feedback response likely required to maintain energy homeostasis. (Endocrinology 152: 4138 -4147, 2011) L eptin, an adipocyte-derived hormone and product of the ob gene, acts on its receptor in the hypothalamus to reduce appetite and body weight (1, 2). Several studies have demonstrated this anorexigenic role of leptin, because mutations in the ob gene (ob/ob mice) or leptin receptor (db/db mice) are associated with morbid obesity, and both central and peripheral administration of leptin decreases food intake in a number of species (3). Although this leptin-induced reduction in appetite has been found to occur through hypothalamic circuitry comprised of both orexigenic [i.e. neuropeptide Y (NPY)] and anorexigenic [i.e. proopiomelanocortin (POMC)] peptides, the mechanisms involved have yet to be defined (4-6). NPY neurons have emerged as a key target of leptin in the hypothalamus, because NPY neurons in the arcuate nucleus (ARC) express Ob-R mRNA and protein (7). NPY is a potent orexigenic peptide
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Recent studies have demonstrated that AMP-activated protein kinase (AMPK) and phosphatidylinositol 3 kinase (PI3K) signaling are essential in the maintenance of food intake at the level of the hypothalamus (9). Minokoshi et al. (10) have demonstrated that exogenous leptin administration inhibits AMPK activity in the ARC. Inhibitor studies have further demonstrated that hypothalamic AMPK activity is essential for the anorexigenic action of leptin (11) . Studies have also strongly implicated the PI3K pathway in the hypothalamic neurons that influence food intake and body weight (12) (13) (14) . The PI3K pathway has been considered a major signaling cascade in mediating the action of metabolic hormones insulin and leptin as demonstrated both in vitro and in vivo (15) . Although both of these signaling mechanisms are critical in the leptin-mediated regulation of energy balance, neither of these signaling pathways has been directly linked to leptin-mediated changes in NPY secretion.
Elevated leptin levels observed in obese subjects do not result in a decrease in feeding. As a result, the failure of high leptin levels to suppress feeding and decrease body weight suggests the presence of resistance to the anorexigenic effect of leptin centrally (16) . Researchers have hypothesized that signaling defects in hypothalamic neurons are a primary cause of leptin resistance. Mü nzberg et al. (17, 18) showed that in diet-induced obese mice, recombinant leptin completely failed to activate signal transducer and activator of transcription (STAT)3 in hypothalamic extracts, indicating leptin resistance in the hypothalamus of diet-induced obese mice. Because Mü nzberg et al. used whole hypothalamic extracts, the precise neuronal populations that develop leptin resistance remain unknown. Further studies localized leptin resistance specifically to the ARC. After 16 wk of high-fat diet feeding, leptin-activated phospho-STAT3 staining within the ARC was dramatically decreased. The characteristics of specific neuronal populations that become leptin resistant in the ARC are unknown. However, the specific neurons that exist in the ARC that express leptin receptors include NPY, POMC, and galanin-like peptide neurons (19, 20) . Based on this knowledge, additional studies should examine the individual neuronal subpopulations to determine the precise cell type and mechanisms involved in leptin resistance.
The direct signaling mechanisms through which leptin acts to regulate NPY secretion has not been established, mainly due to the lack of appropriate cell models for these studies and the difficulty of studying these processes in vivo, because the intact hypothalamus consists of a heterogeneous population of multiple cell types. To circumvent this problem, we have established a method to immortalize individual hypothalamic neurons from both embryonic-and adult-derived primary cultures (21, 22) . Here, we investigated the ability of leptin to directly regulate NPY secretion and the signaling mechanisms required for this regulation. In addition, we examine the effect of prolonged leptin exposure on NPY secretory and signaling responses to leptin. These studies were completed with a novel mHypoA-NPY/green fluorescent protein (GFP) cell line that was developed from a 2-month-old NPY-GFP transgenic mouse and a clonal, immortalized cell line, mHypoA-59, that was derived from hypothalamic primary culture of a 2-month-old female mouse. Our results demonstrate the importance of AMPK and PI3K signaling in the leptin-mediated regulation of NPY secretion and that NPY cell lines become resistant to prolonged leptin exposure. We also introduce novel mHypoA-NPY/GFP and mHypoA-59 neuronal cell lines that can be used to further study the mechanistic regulation of NPY neurons by hormonal modulators.
Materials and Methods

mHypoA-NPY/GFP cell line immortalization and flow cytometry
Primary hypothalamic cultures were isolated from 2-monthold NPY-GFP mice [strain B6.FVB-Tg(Npy-hrGFP)1Lowl/J generated by Bradford Lowell (Beth Israel Deaconess Medical Center, Boston, MA) and available through The Jackson Laboratory, Bar Harbor, ME]. NPY-GFP transgenic mice were housed under standard viviarium conditions in a 12-h light, 12-h dark cycle with food and water available ad libitum for the duration of each experiment. All procedures were conducted in accordance with the regulations of the Canadian Council on Animal Care and approved by the University of Toronto Animal Care Committee. Primary hypothalamic cultures were treated with 10 mg/ml recombinant rat ciliary neurotrophic factor for 5-7 d and immortalized using fresh virus-containing medium harvested from confluent culture of 2 cells (psitex cells) harboring the intact cDNA sequence for simian virus 40 large T antigen and neomycin resistance gene, as previously described (21, 22) . Cells were than sorted on a BD FACSAria cell sorter (Becton Dickinson, Franklin Lakes, NJ) with a 100-micron nozzle tip and sheath pressure at 20 with a purity greater than 95%. mHypoA-NPY/GFP immortalized cells were sorted on GFP fluorescence after gating to remove cell aggregates. All fluorescence-activated cell sorting was performed in the Faculty of Medicine Flow Cytometry Facility, University of Toronto. These cells represent the entire population of mHypoA-NPY/ GFP neurons and have not been further subcloned. The mHypoA-59 cell line was generated as previously described (21, 22) and represents a clonal, immortalized cell line expressing NPY originating from hypothalamic primary culture derived from a 2-month-old female mouse.
Cell culture and reagents
mHypoA-NPY/GFP and mHypoA-59 cell lines were grown in monolayer in DMEM (Sigma-Aldrich, Inc., Oakville, Ontario, Canada) supplemented with 5% fetal bovine serum (FBS) (HyClone Laboratories, Inc., Logan, UT), 4.5 mg/ml glucose and 1% penicillin/streptomycin and maintained at 37 C in an atmosphere of 5% CO 2 
RT-PCR and quantitative RT-PCR (qRT-PCR)
Total RNA was isolated using the guanidinium isothyiocyanate phenol choloroform extraction method as previously described (26) . cDNA was made using the Applied Biosystems High Capacity cDNA Reverse Transcriptase kit (Applied Biosystems, Foster City, CA). For the semiqRT-PCR, Mango Taq polymerase was used according to the manufacturer's protocol (Bioline, Taunton, MA). PCR products were electrophoresed in a 2% agarose gels and stained in an ethidium bromide solution (10 mg/ml ethidium bromide in 300 ml 1ϫ Tris-acetic acid-EDTA). Gels were visualized under UV light using Kodak Image Station 2000R using Kodak 1D Image Analysis Software 3.6 (Eastman Kodak Company, Rochester, NY). For the c-fos experiments, mHypoA-NPY/GFP and mHypoA-59 neurons were serum starved for 8 h before treatment with 5% FBS with 100 nM leptin or vehicle over a 60-min time course. At indicated time points, RNA was extracted from cell lysates for qRT-PCR analysis. cDNA was made using the Applied Biosystems High Capacity cDNA Reverse Transcriptase kit. Real-time qRT-PCR reactions were performed with 200 ng of cDNA template using SYBR green PCR master mix and run on the Applied Biosystems Prism 7000 real-time PCR machine. RNA was probed against c-fos, and data were standardized against the histone housekeeping gene. Primer sequences, annealing temperatures, and amplicon sizes are described in Supplemental Table 1 , published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org.
Enzyme immunoassay (EIA)
mHypoA-NPY/GFP and mHypoA-59 neurons were grown to 90% confluency and then serum starved in DMEM for 4 h before incubation with 10 nM leptin, vehicle or 60 mM KCl (15 min) for 1 h at 37 C. Pharmacological inhibitors used in these experiments were applied as described above. For the leptin-resistance studies, the cells were pretreated with 10 nM leptin or vehicle for 8 or 24 h. At time zero, the cells were washed with 1ϫ PBS and placed in fresh serum-free medium for 2 h. Cells were then rechallenged with leptin, and media were collected 8 or 24 h later. Media were collected (in triplicate), and NPY-like immunoreactivity was measured by EIA (Phoenix Pharmaceuticals, Burlingame, CA) according to the manufacturer's protocol (assay sensitivity, 0.09 ng/ml).
Western blot analysis
Protein from confluent mHypoA-59 or mHypoA-NPY/GFP cells was isolated as previously described (27) . Protein concentration was determined by the bicinchoninic acid assay protein assay kit (Thermo Scientific, Vernon Hills, IL). Total protein (25 g) was resolved on SDS-PAGE gels and blotted onto ImmunBlot polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA). The resulting blot was blocked with 2-3% BSA in Trisbuffered saline containing 0.2% Tween 20 and incubated with primary antibody (Ab) overnight at 4 C. Phospho-AMPK (Thr172, 1:1000), was purchased from Cell Signaling Technologies, Inc., and G protein ␤-subunit (1:1000) Ab was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Immunoreactive bands were visualized with horseradish peroxidase-labeled secondary antirabbit IgG at a 1:10,000 dilution and enhanced chemiluminescence (ECL) kit (GE Healthcare, New York, NY), as described by the manufacturer. Protein was visualized on a Kodak Image Station 2000R using Kodak 1D Image Analysis Software 3.6 (Eastman Kodak Company), allowing for the bands to be resolved within the linear range due to continuous digital imaging.
Immunocytochemistry (ICC)
All cell lines were cultured for ICC on eight-well slides (BD Falcon, BD Biosciences, Mississauga, Ontario, Canada). Once the cells reached the appropriate confluence on the slides, they were treated as follows. Cells were washed twice with PBS and then fixed using 4% paraformaldehyde (Company, in PBS) for 15 min at room temperature. Cells were washed twice with PBS and then permeated with 0.2% Triton X-100 (in PBS) (SigmaAldrich, Inc.) for 20 min at room temperature. After this step, cells were washed twice with PBS and blocked in 5% BSA and 0.1% Triton X-100 (in PBS) overnight at 4 C. Slides were then incubated with primary Ab for 2 h at room temperature. Primary Ab were diluted 1:200 in Ab dilution buffer [1% BSA and 0.1% Triton X-100 (in PBS)] (GFP from Abcam, Inc., Cambridge, MA; and NPY from Santa Cruz Biotechnology, Inc.). Control wells were incubated with 1% BSA and 0.1% Triton X-100 (in PBS). Cells were then subjected to six 5-min PBS washes and then incubated with Alexa Fluor 488 donkey antimouse and/or Alexa Fluor 555 goat antirabbit secondary Ab diluted 1:500 in Ab dilution buffer, combined with the TO-PRO-3 nuclear stain (1: 1000 dilution) for 1 h (Invitrogen Corp., Carlsbad, CA). Control wells were also incubated with the secondary Ab, and TO-PRO-3 in the appropriate dilution. Cells were once again subjected to six 5-min washes with PBS, after which the gaskets were removed from the eight-well slides and mounted with ProLong Gold Antifade Reagent (Invitrogen Corp.). Fixed cells were then visualized with a confocal laser-scanning microscope at a magnification of ϫ40 (LSM 510; Carl Zeiss, Oberkochen, Germany). GFP fluorescence was excited by the 488-nm argon laser line, NPY was excited by the 543-nm helium-neon laser line, and TO-PRO-3 was excited by the 633-nm helium-neon laser line.
Statistical analysis
Data are presented as the mean Ϯ SEM. Data were analyzed by one-or two-way ANOVA followed by a Bonferroni multiple comparisons test or by a Student's t test using GraphPad Prism (GraphPad Software, Inc., San Diego, CA), as indicated in the figure legends, with the exception of the three-way ANOVA. The three-way ANOVA were performed on SigmaStat version 2.01 for Windows (Jandel Scientific, San Rafael, CA). Experiments were performed on three to twelve separate occasions. Comparisons were considered statistically significant at P Ͻ 0.05. represents the entire population of NPY/GFP neurons that were capable of being immortalized in primary culture and has not been further subcloned. The mHypoA-NPY/GFP line was probed for NPY and GFP protein using specific Ab and visualized using ICC to confirm cell phenotype (Fig. 1A) . All neurons in culture expressed both NPY and GFP. The mHypoA-59 cell line was generated as previously described (21, 22) and represents a clonal, immortalized cell line expressing NPY originating from hypothalamic primary culture derived from a 2-month-old female mouse. The mHypoA-59 expresses only NPY protein, as expected, whereas the mHypoA-1/3 was used as a negative control line, because it does not express NPY mRNA or protein (Fig. 1A) . mHypoA-NPY/GFP and mHypoA-59 cell lines were further characterized for neuronal markers, receptors, and neuropeptides (Fig. 1B) . The cell lines express specific neuronal markers and exhibit a neuronal morphology. They grow in a monolayer and have a doubling time of 2-3 d, whereas maintaining a stable phenotype over at least 20 passages. Importantly, they release detectable and regulated levels of NPY.
Results
Characterization
Leptin directly decreases NPY secretion in the mHypoA-NPY/GFP and mHypoA-59 cell lines
Although evidence indicates that leptin can regulate NPY mRNA in vivo, it is not known whether leptin can directly regulate NPY secretion (28) . mHypoA-59 and mHypoA-NPY/GFP neurons were exposed to leptin (10 nM) for 1 h. Analysis of the results indicates that in the mHypoA-59 and mHypoA-NPY/GFP neurons, NPY secretion is significantly reduced by leptin (mHypoA-59: vehicle, 1.0 Ϯ 0.06 and leptin, 0.78 Ϯ 0.03; mHypoA-NPY/GFP: vehicle, 1 Ϯ 0.14 and leptin, 0.8 Ϯ 0.04) ( Fig.  2A) . Although previous reports have demonstrated that leptin can directly decrease NPY mRNA, this is the first demonstration of direct leptin signaling resulting in the suppression of NPY secretion. KCl treatments resulted in an approximately 1.4-fold increase in NPY secretion in both cell lines, indicating that the cells are responsive to depolarization, as expected from previous analysis of NPY cell lines.
It has been suggested that leptin may act at the level of the NPY neuron through mechanisms involving cellular hyperpolarization (15) . We therefore treated the cells with 5% FBS (positive activator of c-fos) without or with 100 nM leptin over a 1 h time course to determine the effect on c-fos mRNA expression levels. c-fos is a classic indicator of neuronal activation and thus would be expected to be dampened if the neurons are hyperpolarized. We found that in both the mHypoA-NPY/GFP and mHypoA-59 cell lines the levels of c-fos mRNA were decreased upon addition of leptin (Fig. 2B) . This indicates that leptin may be acting through a downstream signaling cascade to hyperpolarize the neurons (15).
Leptin decreases NPY secretion in the mHypoA-59 and mHypoA-NPY/GFP neurons via AMPK and PI3K pathways
Accumulating evidence shows that NPY neurons are involved in the anorexigenic action of leptin (4, 13, 29, 30) . To determine the signaling mechanisms activated by leptin in the mHypoA-NPY/GFP (Fig. 3 ) and mHypoA-59 (Fig. 4) cell lines, we used Western blot analysis to analyze the phosphorylation status of key signaling kinases. Leptin transiently decreased phospho-AMPK, indicating AMPK activity inhibition. To determine whether the PI3K, MAPK, or AMPK pathways are required for the leptin-mediated decrease in NPY secretion, mHypoA-59 and mHypoA-NPY/GFP neurons were pretreated with pharmacological inhibitors for 1 h, followed by a 1-h leptin cotreatment. We found that inhibiting either AMPK with Compound C or the PI3K pathway with LY294002 prevented the leptin-mediated decrease in NPY secretion. These data demonstrate that the AMPK and PI3K pathways are important mediators of the anorexigenic action of leptin in the putative feeding-related NPY cell lines mHypoA-59 and mHypoA-NPY/GFP.
Aminoimidazole carboxamide ribonucleotide (AICAR) directly stimulates NPY secretion in mHypoA-59 and mHypoA-NPY/GFP neurons
Treatment with AICAR activates AMPK activity in numerous cell types, including neuronal cells (31, 32) . We analyzed the effect of AICAR on NPY secretion in the presence and absence of leptin in the mHypoA-59 and mHypoA-NPY/GFP neurons (Fig. 5) . AICAR alone di- rectly increased NPY secretion in the mHypoA-59 and mHypoA-NPY/GFP neurons. Together, these results indicate that AMPK activity is critical for NPY secretory release and provides a potential mechanism by which central AICAR administration directly induces food intake.
Leptin pretreatment attenuates leptin-mediated phosphorylation of AMPK in mHypoA-NPY/GFP neurons High-fat diets or hyperleptinemia often result in impaired leptin signaling, a state defined as leptin resistance. To determine the effects of prolonged leptin exposure on neuronal signaling, we pretreated mHypoA-NPY/GFP neurons with leptin for 8 or 24 h. After leptin pretreatment, cells were washed with PBS, placed in fresh medium for 2 h, and then rechallenged with leptin to determine neuronal responsiveness. Using Western blot analysis, we determined that a 24-h leptin pretreatment prevented the leptin-induced reduction in phospho-AMPK (Fig. 6) . These data indicate that the endogenous leptin signaling in a NPY cell model is impaired with prolonged leptin exposure.
Leptin pretreatment attenuates the leptin-mediated decrease in NPY secretion in mHypoA-NPY/ GFP neurons
To address whether impaired leptin signaling induced from prolonged leptin exposure can prevent the leptin-mediated reduction in NPY secretion, mHypoA-NPY/GFP cells were pretreated with leptin for 8 or 24 h. After leptin pretreatment, cells were washed with PBS, placed in fresh medium for 2 h, and then rechallenged with leptin for 1 h. Media were collected, and NPY immunoreactivity was measured using EIA. We found that 8 and 24 h of leptin pretreatment prevented the leptin-mediated decrease in NPY (Fig. 7) . These results suggest that leptin responsiveness decreases in NPY neurons after experiencing hyperleptinemic conditions and is consistent with the possibility that cellular leptin resistance occurs at least partially through hypothalamic NPY neuronal populations.
Discussion
Whether leptin can act directly at the level of NPY neurons is not currently known, because studies in explants and animals cannot differentiate between direct and indirect effects of hormonal exposure. To circumvent this problem, we have previously characterized clonal, embryonic-or adultderived hypothalamic cell lines that express NPY (21, 22) . This method was also used to generate a clonal cell line mHypoA-59 from adult-derived primary culture from a female mouse. We have now also generated a novel, immortalized mHypoA-NPY/GFP NPY-expressing cell line, representing the entire NPY population in the hypothalamus in primary culture, that was used to investigate the cellular events involved in leptin action on NPY secretory release. We have previously used a number of the cell models generated in our laboratory to study the signal transduction events initiated by leptin exposure (23, (33) (34) (35) (36) (37) .
Here, leptin was demonstrated to act through the AMPK and PI3K signaling pathways to directly reduce NPY secretion. In addition, using this cell model, we have evidence that suggests NPY neurons become leptin resistant during times of prolonged leptin exposure. Evidence clearly indicates that the central nervous system, particularly the hypothalamus, is a major site of leptin action (7, 38) . Ob-Rb is critical for intracellular leptin signaling and has been localized to a number of hypothalamic nuclei responsible for metabolic function, including the ARC, dorsomedial nucleus, lateral hypothalamus, and ventral medial nucleus (7, 38, 39) . Two important neuropeptides, POMC and NPY, which are involved in both feeding and reproductive homeostasis, have emerged as key hypothalamic targets of leptin. Previous reports have demonstrated that both the peripheral and central administration of leptin can directly decrease NPY mRNA (5) . In our studies, we have demonstrated that leptin can directly decrease NPY secretion by approximately 20% from the NPY-GFP and mHypoA-59 cell lines. Functionally, this 20% reduction in NPY secretion could produce a significant reduction in feeding in vivo (40, 41) . Bewick et al. (40) previously demonstrated that a 30% reduction in NPY immunoreactivity results in a 16% reduction in food intake in 4-and 6-wk-old mice. This difference was further increased in 14-to 16-wk-old mice with a 28% reduction in food intake. The overall reductions in feeding culminated in a 53% reduction in total body fat at 16 wk of age (40) . We therefore speculate that the direct and rapid decrease in NPY secretion observed in our in vitro experiments may produce a similar decrease in feeding as observed by the in vivo studies. This direct and rapid decrease by leptin may cultivate the leptin-mediated reduction appetite that is well established (5) .
Leptin activates multiple nongenomic signaling pathways that are likely critical in the release of hypothalamic neuropeptides to regulate appetite. Leptin activates STAT3 proteins that bind to the phosphorylated 1138 tyrosine residue sites on Ob-Rb, which are key signaling molecules in POMC neurons (42, 43) . However, deletion of STAT3 from NPY neurons does not alter leptin-mediated NPY mRNA expression responses in vivo (43, 44) . PI3K stimulation by leptin has been observed in cultured hypothalamic cells, and inhibition of hypothalamic PI3K activity in mice prevents leptin-mediated decreases in appetite (14, 15, 45) . Interestingly, in hypothalamic slices, leptin appears to elicit cell depolarization via PI3K activity in POMC neurons; in contrast, leptin withdrawal activates the PI3K pathway in NPY neurons, suggesting that leptin hyperpolarizes NPY neurons via PI3K-dependent mechanisms (46, 47) . In fact, leptin has previously been demonstrated to inhibit hypothalamic cell lines by hyperpolarization via K atp -and PI3K-dependent mechanisms (15, 48) . Most recently, considerable leptin research has focused on AMPK, an energy sensor activated by an increasing ratio of AMP:ATP in multiple cell types (31, 49) . AMPK phosphorylates and inactivates acetyl-coenzyme A carboxylase (ACC), a key enzyme in fatty acid synthesis (11, 50) . Leptin has been demonstrated to inhibit AMPK activity in multiple regions of the hypothalamus (9) . In addition, inhibition of hypothalamic AMPK is sufficient to reduce appetite and weight gain (10, 11) . Taken together, leptin is hypothesized to stimulate ACC activity by inhibiting AMPK, ultimately decreasing food intake (9) . Although the anorectic signaling mechanisms of leptin in the whole hypothalamus or specific hypothalamic nuclei have been studied, it is unclear which cell types leptin is acting through and whether leptin directly or indirectly regulates these neuronal cell types. In our studies, leptin directly decreased the phosphorylation status of AMPK, suggesting an increase in ACC activity in our NPY neuronal cell models, mHypoA-59 and mHypoA-NPY/GFP. Through inhibitor analysis, we demonstrate that both the AMPK and PI3K pathways are required for the leptin-mediated reduction in NPY secretion, and we present evidence that this may be through hyperpolarization of the neurons. Conversely, stimulating AMPK activity through AICAR treatment directly stimulated NPY secretion. Together, this is the first study indicating that leptin directly decreases NPY secretion in NPY neuronal cell lines via AMPK-and PI3K-dependent mechanisms, which we suggest could ultimately reduce food intake and appetite in vivo.
Studies document that obese individuals with high levels of leptin undergo a failure to suppress feeding and decrease body weight (12, 16, 51) . This suggests that hyperleptinemia may cause leptin resistance. To date, four mechanisms of leptin resistance have been hypothesized: 1) impaired leptin transport across the blood-brain barrier (52), 2) alterations in leptin signaling (51), 3) perturbations in developmental programming (18) , and 4) increased Ob-R degradation (53, 54) . Although each of these mechanisms may contribute to the entirety of leptin resistance, we examined the effect of prolonged leptin ex-posure on leptin signaling and leptin regulation of NPY secretion in the mHypoA-NPY/GFP neuronal cell line. We found that impaired leptin signaling might contribute to the leptin resistant state, because prolonged leptin exposure (8 and 24 h) prevented the leptin-mediated decrease in AMPK phosphorylation. In addition to attenuated leptin signaling in the mHypoA-NPY/GFP cell line, sustained leptin treatments also prevented the leptin-mediated decrease in NPY secretion. These results support the notion of neuronal resistance to prolonged hyperleptinemia and indicate for the first time that defective AMPK signaling and impaired NPY secretion may contribute to the leptin resistant state.
Leptin is a potent anorexigenic hormone that decreases feeding by acting on neuronal circuitry of the hypothalamus. Although many studies have illustrated the effect of leptin in vivo, few studies have examined the direct regulation of NPY secretion by leptin and the signaling mechanisms induced. Here, we have demonstrated that leptin directly decreases NPY secretion via the PI3K and AMPK signaling pathways. Studies have yet to confirm the specific neuronal populations in the ARC that are susceptible to leptin resistance and whether or not the energy sensing kinase, AMPK, is altered in leptin resistant states. In this study, we have demonstrated that the leptin-mediated decrease in AMPK phosphorylation is greatly attenuated in NPY neuronal cell lines with prolonged exposure to leptin. This impaired AMPK signaling was accompanied by the inability of the NPY cell lines to respond appropriately to the leptin-mediated decrease in NPY secretion. We provide evidence of impaired AMPK signaling and NPY secretory response to prolonged leptin exposure. It provides a potential role for cellular determinants in the development of leptin resistance and may relate directly to the underlying impaired signaling mechanisms that ultimately contribute to obese states. Importantly, all experiments were performed using the newly generated mHypoA-NPY/GFP and mHypoA-59 cell models. These cell lines will be useful tools to understand the control mechanisms used by mature NPY neurons in terms of basic cellular function and direct hormonal regulation and the perturbation of these events in leptin resistant conditions.
